Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Gastrointestinal Cancer Channel is supported with funding from Revolution Medicines (Silver).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

Share this video  

ASCO 2021 | Future directions in bile duct cancers

Rachna T. Shroff, MD, University of Arizona Cancer Center, Tucson, AZ, discusses progress in biliary tract cancers and touches on key areas of unmet need, such as improving chemotherapy regimens in patients, as well as identifying agents for patients without druggable mutations, of which immunotherapy may prove useful. Finally, Dr Shroff highlights the importance of understanding and overcoming resistance in patients treated with targeted therapies. This interview took place at the American Society of Clinical Oncology (ASCO) 2021 Virtual Meeting.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.